Schizophrenia shows a unique metabolomics signature in plasma
about
Omics-Based Biomarkers: Application of Metabolomics in Neuropsychiatric DisordersFrom Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids MetabolismWhat Have Mass Spectrometry-Based Proteomics and Metabolomics (Not) Taught Us about Psychiatric Disorders?Altered brain arginine metabolism in schizophreniaInflammation and the two-hit hypothesis of schizophrenia.Biomarkers for combat-related PTSD: focus on molecular networks from high-dimensional data."Gestaltomics": Systems Biology Schemes for the Study of Neuropsychiatric Diseases.Reduced Mismatch Negativity is Associated with Increased Plasma Level of Glutamate in First-episode PsychosisImpaired metabolic reactivity to oxidative stress in early psychosis patientsNon-targeted metabolite profiling reveals changes in oxidative stress, tryptophan and lipid metabolisms in fearful dogs.Effects of smoking and smoking cessation on human serum metabolite profile: results from the KORA cohort studyOptimization and validation of a capillary electrophoresis laser-induced fluorescence method for amino acids determination in human plasma: application to bipolar disorder study.Multiplatform metabolome and proteome profiling identifies serum metabolite and protein signatures as prospective biomarkers for schizophrenia.Bioanalysis of acetylcarnitine in cerebrospinal fluid by HILIC-mass spectrometry.Potential serum biomarkers from a metabolomics study of autismHuman serum metabolic profiles are age dependent.Metabolomic Profiling of Post-Mortem Brain Reveals Changes in Amino Acid and Glucose Metabolism in Mental Illness Compared with ControlsAlcohol-induced metabolomic differences in humans.Identification of sex-specific urinary biomarkers for major depressive disorder by combined application of NMR- and GC-MS-based metabonomics.Serum metabolite profile associates with the development of metabolic co-morbidities in first-episode psychosis.Changes in metabolite profiles caused by genetically determined obesity in mice.Twin studies in inherited eye disease.Schizophrenia biomarkers: translating the descriptive into the diagnostic.Neuronal nitric oxide synthase (NOS1) and its adaptor, NOS1AP, as a genetic risk factors for psychiatric disorders.Can proteomics-based diagnostics aid clinical psychiatry?Specialized Information Processing Deficits and Distinct Metabolomic Profiles Following TM-Domain Disruption of Nrg1.Short overview on metabolomic approach and redox changes in psychiatric disorders.Combined 1H-NMR and 1H-13C HSQC-NMR to improve urinary screening in autism spectrum disorders.Familial resemblance for serum metabolite concentrations.Fearful dogs have increased plasma glutamine and γ-glutamyl glutamine
P2860
Q26784904-44794EA8-2161-4C71-A512-00BBD2495127Q28067617-714CC8AD-33DB-474D-BC31-35970A21B477Q28083512-3AAF379C-B669-4873-A266-A12FD3BA1619Q30374351-DEAAEB15-63A7-4287-88A1-FA8A6C1B4389Q30422062-2C92FBCF-1241-4629-97A5-A111A8155CDAQ30849692-31F84EEB-B3F1-4FA1-BE92-ADE7A9FB6E0AQ33651168-021D7E69-4B0E-4563-AC95-DB2445629BCFQ33720060-FF2350F7-86CF-4C15-901F-62CEED54D72BQ34048645-D7A229F5-A81B-48AD-8CB0-9B1D9A6005C2Q34513600-1F43D3C3-4B8F-4F53-8595-12F9959E6691Q34622940-37A55B1E-2D7B-4AE2-A5AC-D88697768B9AQ34628120-C25FBFF6-C5F1-4D16-AE07-5832B704F453Q35162008-A86AD57B-E140-4868-A267-4816C06DEFD0Q35567205-4150F9D5-2709-4DB2-8DD6-A941623DD731Q36395466-AE35768E-EC2B-46CF-B663-60FAD8596D66Q36498753-FB6252D2-790F-4765-8535-CA906EF59246Q36743314-16AEC3ED-9696-4DF4-8C1B-3925DE4A4BDBQ37065278-38E5BE3B-245C-4BE7-AA4C-094037F94D24Q37648213-6AC944CB-491F-4165-AB01-84E20AF8BA4AQ37648311-C9BD2E89-C3B7-43AA-AAFA-BA5E9826ECFFQ37699656-ADF4AA66-FBAD-49B4-BFC9-1EDE6060A55DQ38151962-D7D993E2-2505-4C2E-8819-5B425057797EQ38324251-FAD038A6-6D89-4A40-933A-3217E71108BFQ38328635-4A46B151-D3CD-40EF-85E0-86494886DBBCQ38392369-984F3662-703A-480B-A05A-511422C3DA4FQ38879553-935A7E95-A72B-46F6-9FC3-09B6E661FD82Q41791000-1C57E8B9-405F-4D9D-87F9-7960CFC1A769Q50306889-FF84D374-633F-4C7D-A437-7F3C4BE7A7A8Q51335122-EABC5439-0DE8-4EED-9FA6-CB33D2DF1E85Q58107332-29C628AC-B643-41E1-A0BA-FEADACB02D5C
P2860
Schizophrenia shows a unique metabolomics signature in plasma
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Schizophrenia shows a unique metabolomics signature in plasma
@ast
Schizophrenia shows a unique metabolomics signature in plasma
@en
type
label
Schizophrenia shows a unique metabolomics signature in plasma
@ast
Schizophrenia shows a unique metabolomics signature in plasma
@en
prefLabel
Schizophrenia shows a unique metabolomics signature in plasma
@ast
Schizophrenia shows a unique metabolomics signature in plasma
@en
P2093
P2860
P50
P356
P1476
Schizophrenia shows a unique metabolomics signature in plasma
@en
P2093
A M Hartmann
I Giegling
P2860
P2888
P356
10.1038/TP.2012.76
P577
2012-08-14T00:00:00Z